非處方藥、醫療設備與診斷產品：全球市場

OTC Drugs, Medical Devices and Diagnostics: Global Markets

出版日期: 2025年01月03日 | 出版商:

BCC Research | 英文 139 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

全球非處方藥、醫療設備和診斷產品市場規模預計將從 2024 年的 2,517 億美元增至 2029 年的 3,597 億美元，預測期內複合年成長率為 7.4%。

非處方藥產業預計將從 2024 年的 1,965 億美元增至 2029 年的 2,717 億美元，預測期內複合年成長率為 6.7%。 OTC 設備和診斷產品產業預計將從 2024 年的 552 億美元成長到 2029 年的 880 億美元，複合年成長率為 9.8%。

本報告調查了全球非處方藥、醫療設備和診斷產品市場，並提供了市場概況、市場影響因素和市場機會分析、法律制度、新興技術和技術發展趨勢以及市場規模趨勢和預測。地區、競爭格局、主要企業概況等進行詳細分析。

細分細分
市場分析：依產品分類
非處方藥
藥品
維生素和礦物質補充劑
非處方藥設備/診斷產品
監控裝置
治療裝置
診斷設備套件
市場分析：依應用分類
呼吸系統疾病
胃腸道疾病
整形外科疾病
心血管疾病
糖尿病
皮膚病
肥胖
耳鼻喉科疾病
睡眠障礙
其他
地域分佈
市場分析：按地區
北美洲
歐洲
亞太地區
其他領域

第6章競爭訊息

市場分析
戰略分析

第7章非處方藥、醫療設備和診斷產品的永續性：ESG 視角

ESG介紹
成藥、醫療設備和診斷的永續性：ESG 視角
ESG 關鍵議題
非處方藥、醫療設備和診斷產品的 ESG 績效分析
BCC的結語

第8章附錄

調查方法
來源
簡稱
公司簡介
ABBOTT
BAYER AG
DSM-FIRMENICH
HALEON GROUP OF CO.
KENVUE
KONINKLIJKE PHILIPS NV
MASIMO
NESTLE
PROCTER & GAMBLE
SANOFI

簡介目錄圖表

Product Code: HLC251B

The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.

The OTC drugs market for OTC drugs, medical devices, and diagnostics is estimated to increase from $196.5 billion in 2024 to reach $271.7 billion by 2029, at a CAGR of 6.7% from 2024 through 2029.

The OTC devices and diagnostics market for OTC drugs, medical devices, and diagnostics is estimated to increase from $55.2 billion in 2024 to reach $88.0 billion by 2029, at a CAGR of 9.8% from 2024 through 2029.

Report Scope:

The current report provides detailed information and estimates through 2029 and market shares for key market players. It details the market size of OTC drugs, medical devices, and diagnostics based on products and applications. Based on product, OTC drugs, medical devices, and diagnostics are categorized into OTC drugs (pharmaceutical drugs and vitamin and mineral supplements) and OTC devices and diagnostics (monitoring devices, therapeutic devices, and diagnostic devices and kits). Based on application, the report is segmented into respiratory disorders, orthopedic diseases, gastrointestinal disorders, diabetes, obesity, cardiovascular diseases, ENT disorders, skin disorders, sleep disorders, and other disorders.

Report Includes:

36 data tables and 69 additional tables
An up-to-date overview of the global markets for OTC drugs, medical devices and diagnostics
Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by product type, application, and geographic region
Discussion of how the rise in the number of diseases are creating a constant need for OTC drugs, medical devices, and diagnostics for disease management
A look at the key market drivers and restraints that will shape the market for OTC drugs, medical devices, and diagnostics over the next five years (2024-2029)
A discussion on ESG challenges and practices in the industry
Review of patents issued for OTC drugs, medical devices, and diagnostics
Assessment of the vendor landscape, including the market shares of leading companies, their product portfolios and financial overviews
Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
Company profiles of major players within the industry, including Haleon Group of Co., Kenvue, Sanofi, and Bayer AG

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview

Introduction
Types of OTC Products
Pharmaceutical OTC Drugs
Vitamin and Mineral Supplements
OTC Medical Devices and Diagnostics
Advantages and Disadvantages of OTC Drugs, Medical Devices, and Diagnostics
Cost Savings Analysis
PESTLE Analysis
Porter's Five Forces Analysis
Bargaining Power of Buyers: High
Bargaining Power of Suppliers: Moderate
Potential of New Entrants to the Market: Moderate
Competition in the Industry: High
Threat of Substitutes: Moderate to High
Regulatory Landscape
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Growing Prevalence of Chronic Diseases and Expanding Geriatric Populations
Increasing Health Awareness
Growing Online Sales Channels and Telehealth Platforms
Market Restraints
Presence of Alternative Methods
Market Opportunities
Emerging Economies
Market Challenges
Misuse and Interactions of OTC Drugs and Medical Devices
Data Privacy and Security Concerns

Chapter 4 Emerging Technologies and Developments

Emerging Technologies
Advanced Drug Delivery
Advanced Wearable Sensors
Artificial Intelligence
Clinical Trials Analysis
Clinical Trials Analysis by Type of Study
Clinical Trials Analysis, by Status
Clinical Trials Analysis, by Phase

Chapter 5 Market Segmentation Analysis

Segmentation Breakdown
Market Analysis by Product
OTC Drugs
Pharmaceutical Drugs
Vitamin and Mineral Supplements
OTC Devices and Diagnostics
Monitoring Devices
Therapeutic Devices
Diagnostic Devices and Kits
Market Breakdown by Application
Respiratory Disorders
Gastrointestinal Disorders
Orthopedic Diseases
Cardiovascular Diseases
Diabetes
Skin Disorders
Obesity
ENT Disorders
Sleep Disorders
Other Disorders
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence

Market Analysis
Strategic Analysis

Chapter 7 Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective

Introduction to ESG
Sustainability in OTC Drug, Medical Device, and Diagnostics: An ESG Perspective
Key ESG Issues
OTC Drug, Medical Device, and Diagnostics ESG Performance Analysis
Concluding Remarks from BCC

Chapter 8 Appendix

Methodology
Sources
Abbreviations
Company Profiles
ABBOTT
BAYER AG
DSM-FIRMENICH
HALEON GROUP OF CO.
KENVUE
KONINKLIJKE PHILIPS N.V.
MASIMO
NESTLE
PROCTER & GAMBLE
SANOFI

簡介目錄圖表

List of Tables

Summary Table : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Product, Through 2029
Table 1 : Difference between Prescription v/s OTC Pharmaceutical Drugs
Table 2 : Top OTC Pharmaceutical Drugs in Major Categories
Table 3 : Top Vitamin and Mineral Supplements in Major Categories
Table 4 : Top OTC Medical Devices and Diagnostics in Major Categories
Table 5 : FDA Medical Device Classification
Table 6 : EU MDR Medical Device Classification
Table 7 : Asia-Pacific: Regulatory Landscape
Table 8 : RoW: Regulatory Landscape
Table 9 : Global: Leading causes of Disease Burden, 2022 v/s 2050
Table 10 : U.S.: Sufferers Using Only OTC Products, 2019
Table 11 : Comparison of FDA-Cleared Health Monitoring Watches
Table 12 : OTC Drugs: Adverse Effects
Table 13 : OTC Drug Interaction with Disorders
Table 14 : Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Type of Study, October 2024
Table 15 : Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Status, October 2024
Table 16 : Clinical Trials in OTC Drugs, Medical Devices, and Diagnostics, by Phase, October 2024
Table 17 : OTC Drugs, Medical Devices and Diagnostics Inclusion, by Product
Table 18 : Global Market for OTC Drugs, Medical Devices and Diagnostics, by Product, Through 2029
Table 19 : Global Market for OTC Drugs, by Region, Through 2029
Table 20 : Global Market for OTC Drugs, by Type, Through 2029
Table 21 : Most Common OTC Cough, Cold and Respiratory Drugs
Table 22 : Most Common OTC Analgesic/Antipyretic
Table 23 : Most Common OTC Gastrointestinal Drugs
Table 24 : Most Common OTC Dermatological Drugs
Table 25 : Key Marketed OTC Pharmaceutical Drugs, by Company
Table 26 : Global Market for Pharmaceutical Drugs, by Region, Through 2029
Table 27 : Key Marketed Vitamin and Mineral Supplements, by Company
Table 28 : Global Market for Vitamin and Mineral Supplements, by Region, Through 2029
Table 29 : Global Market for OTC Devices and Diagnostics, by Region, Through 2029
Table 30 : Global Market for OTC Devices and Diagnostics, by Type, Through 2029
Table 31 : OTC Cardiac Monitoring Devices, by Company
Table 32 : OTC Blood Pressure Monitoring Devices, by Company
Table 33 : OTC Pulse Oximeter, by Company
Table 34 : OTC Glucose Monitoring Devices, by Company
Table 35 : OTC Sleep Monitoring Devices, by Company
Table 36 : Fetal Monitoring Devices, by Company
Table 37 : Global Market for Monitoring Devices, by Region, Through 2029
Table 38 : Pain Management Devices, by Company
Table 39 : Rehabilitation Devices, by Company
Table 40 : Other OTC Devices, by Company
Table 41 : Global Market for Therapeutic Devices, by Region, Through 2029
Table 42 : Diagnostic Devices and Kits, by Company
Table 43 : Global Market for Diagnostic Devices and Kits, by Region, Through 2029
Table 44 : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Application, Through 2029
Table 45 : Global Market for Respiratory Disorders, by Region, Through 2029
Table 46 : Gastrointestinal Disorders: OTC Drug Management
Table 47 : Global Market for Gastrointestinal Disorders, by Region, Through 2029
Table 48 : Global Market for Orthopedic Diseases, by Region, Through 2029
Table 49 : Global Market for Cardiovascular Diseases, by Region, Through 2029
Table 50 : Worldwide Diabetes Estimates (20-79 Years), by Region, 2021-2045
Table 51 : Global Market for Diabetes, by Region, Through 2029
Table 52 : Global Market for Skin Disorders, by Region, Through 2029
Table 53 : Global Market for Obesity, by Region, Through 2029
Table 54 : Global Market for ENT Disorders, by Region, Through 2029
Table 55 : Global Market for Sleep Disorders, by Region, Through 2029
Table 56 : Global Market for Other Disorders, by Region, Through 2029
Table 57 : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Region, Through 2029
Table 58 : North American Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029
Table 59 : European Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029
Table 60 : Asia-Pacific Market for OTC Drugs, Medical Devices, and Diagnostics, by Country, Through 2029
Table 61 : OTC Pharmaceutical Drugs: Market Player Share Analysis, 2023
Table 62 : OTC Drugs, Medical Devices, and Diagnostics: Recent Strategic Developments, 2022-2024
Table 63 : ESG Rankings for OTC Drug, Medical Device, and Diagnostics Companies, 2024*
Table 64 : ESG: Environmental Overview
Table 65 : ESG: Social Overview
Table 66 : ESG: Governance Overview
Table 67 : Report Specific Information Sources
Table 68 : Abbreviations Used in OTC Drugs, Medical Devices, and Diagnostics Market
Table 69 : Abbott: Company Snapshot
Table 70 : Abbott: Financial Performance, FY 2022 and 2023
Table 71 : Abbott: Product Portfolio
Table 72 : Abbott: News/Key Developments, 2021-2024
Table 73 : Bayer AG: Company Snapshot
Table 74 : Bayer AG: Financial Performance, FY 2022 and 2023
Table 75 : Bayer AG: Product Portfolio
Table 76 : DSM-Firmenich: Company Snapshot
Table 77 : DSM-Firmenich: Financial Performance, FY 2022 and 2023
Table 78 : DSM-Firmenich: Product Portfolio
Table 79 : DSM-Firmenich: News/Key Developments, 2023
Table 80 : Haleon Group of Co.: Company Snapshot
Table 81 : Haleon Group of Co.: Financial Performance, FY 2022 and 2023
Table 82 : Haleon Group of Co.: Product Portfolio
Table 83 : Haleon Group of Co.: News/Key Developments, 2023 and 2024
Table 84 : Kenvue: Company Snapshot
Table 85 : Kenvue: Financial Performance, FY 2022 and 2023
Table 86 : Kenvue: Product Portfolio
Table 87 : Koninklijke Philips N.V.: Company Snapshot
Table 88 : Koninklijke Philips N.V.: Financial Performance, FY 2022 and 2023
Table 89 : Koninklijke Philips N.V.: Product Portfolio
Table 90 : Masimo: Company Snapshot
Table 91 : Masimo: Financial Performance, FY 2022 and 2023
Table 92 : Masimo: Product Portfolio
Table 93 : Masimo: News/Key Developments, 2024
Table 94 : Nestle: Company Snapshot
Table 95 : Nestle: Financial Performance, FY 2022 and 2023
Table 96 : Nestle: Product Portfolio
Table 97 : Nestle: News/Key Developments, 2024
Table 98 : Procter & Gamble: Company Snapshot
Table 99 : Procter & Gamble: Financial Performance, FY 2022 and 2023
Table 100 : Procter & Gamble: Product Portfolio
Table 101 : Sanofi: Company Snapshot
Table 102 : Sanofi: Financial Performance, FY 2022 and 2023
Table 103 : Sanofi: Product Portfolio
Table 104 : Sanofi: News/Key Developments, 2023 and 2024

List of Figures

Summary Figure : Global Market for OTC Drugs, Medical Devices, and Diagnostics, by Product, 2021-2029
Figure 1 : Advantages and Disadvantages of OTC Drugs, Medical Devices, and Diagnostics
Figure 2 : OTC Drugs, Medical Devices, and Diagnostics: PESTLE Analysis
Figure 3 : Market Dynamics of OTC Drugs, Medical Devices, and Diagnostics
Figure 4 : Global Population Share Above 65 Years, 2019-2023
Figure 5 : Security Risk of Wearable
Figure 6 : Emerging Trends/Technologies in the OTC Drugs, Medical Device and Diagnostics Market
Figure 7 : Global Market Shares for OTC Drugs, Medical Devices and Diagnostics, by Product, 2023
Figure 8 : Global Market Shares for OTC Drugs, by Type, 2023
Figure 9 : Global Market Shares for OTC Devices and Diagnostics, by Type, 2023
Figure 10 : Global Market Shares for OTC Drugs, Medical Devices, and Diagnostics, by Application, 2023
Figure 11 : Percentage of Population Aged 65 Years and Above, by Region, 2050
Figure 12 : Worldwide Diabetes Estimates (20-79 Years), by Region, 2021, 2030 and 2045
Figure 13 : Global Market Shares for OTC Drugs, Medical Devices, and Diagnostics, by Region, 2023
Figure 14 : North American Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023
Figure 15 : U.S. Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 16 : Canadian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 17 : European Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023
Figure 18 : German Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 19 : U.K. Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 20 : French Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 21 : Italian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 22 : Rest of European Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 23 : Asia-Pacific Market Shares of OTC Drugs, Medical Devices, and Diagnostics, by Country, 2023
Figure 24 : Chinese Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 25 : Indian Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 26 : Japanese Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 27 : Rest of Asia-Pacific Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 28 : Rest of the World Market for OTC Drugs, Medical Devices, and Diagnostics, 2021-2029
Figure 29 : Major Vitamin and Mineral Supplements Players
Figure 30 : Major OTC Medical Device Players
Figure 31 : ESG Pillars
Figure 32 : Advantages of ESG for Companies
Figure 33 : Key ESG Issues in the OTC Drug, Medical Device, and Diagnostics Industry
Figure 34 : Abbott: Revenue Shares, by Business Unit, FY 2023
Figure 35 : Abbott: Revenue Shares, by Country/Region, FY 2023
Figure 36 : Bayer AG: Revenue Shares, by Business Unit, FY 2023
Figure 37 : Bayer AG: Revenue Shares, by Country/Region, FY 2023
Figure 38 : DSM-Firmenich: Revenue Shares, by Business Unit, FY 2023
Figure 39 : DSM-Firmenich: Revenue Shares, by Country/Region, FY 2023
Figure 40 : Haleon Group of Co.: Revenue Shares, by Business Unit, FY 2023
Figure 41 : Haleon Group of Co.: Revenue Shares, by Country/Region, FY 2023
Figure 42 : Kenvue: Revenue Shares, by Business Unit, FY 2023
Figure 43 : Kenvue: Revenue Shares, by Country/Region, FY 2023
Figure 44 : Koninklijke Philips N.V.: Revenue Shares, by Business Unit, FY 2023
Figure 45 : Koninklijke Philips N.V.: Revenue Shares, by Country/Region, FY 2023
Figure 46 : Masimo: Revenue Shares, by Business Unit, FY 2023
Figure 47 : Masimo: Revenue Shares, by Country/Region, FY 2023
Figure 48 : Nestle: Revenue Shares, by Business Unit, FY 2023
Figure 49 : Nestle: Revenue Shares, by Country/Region, FY 2023
Figure 50 : Procter & Gamble: Revenue Shares, by Business Unit, FY 2023
Figure 51 : Procter & Gamble: Revenue Shares, by Country/Region, FY 2023
Figure 52 : Sanofi: Revenue Shares, by Business Unit, FY 2023
Figure 53 : Sanofi: Revenue Shares, by Country/ Region, FY 2023